Search research articles
Contact Us
Filters
Showing results (341-350 of 578) with videos related to
Page
of 58
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, et al.
International Journal of Cancer
|
April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Eva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer
|
May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium
Gesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
Gemma G Kenter, Stefano Greggi, Ignace Vergote, et al.
Cancers
|
September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
Sabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Ignace Vergote, Neil J Finkler, James B Hall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Nicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study
Mani Nassir, Jun Guan, Hrvoje Luketina, et al.
BMC Cancer
|
September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium
Anna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Gynecologic Oncology
|
July 15, 2014
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer
Ignace Vergote, Russell J Schilder, Charles H Pippitt, et al.
Page
of 58
Search research articles
Search
Showing results (341-350 of 578) with videos related to
Sort By:
Page
of 58
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, et al.
International Journal of Cancer
|
April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Eva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer
|
May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium
Gesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
Gemma G Kenter, Stefano Greggi, Ignace Vergote, et al.
Cancers
|
September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
Sabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Ignace Vergote, Neil J Finkler, James B Hall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2021
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Nicole Concin, François Planchamp, Nadeem R Abu-Rustum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study
Mani Nassir, Jun Guan, Hrvoje Luketina, et al.
BMC Cancer
|
September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium
Anna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Gynecologic Oncology
|
July 15, 2014
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer
Ignace Vergote, Russell J Schilder, Charles H Pippitt, et al.
Page
of 58